PolyActiva

Developing products that enable drug release from medical devices
PolyActiva
Operating

PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers.

Investors
Investor

Brandon Capital Partners

Investor

Medical Research Commercialisation Fund (MRCF)

Investor

Yuuwa Capital

Images
Taken on 2017-12
 Location
Melbourne
 Links
 People
No information available.
 Tags
#hardware
#health
#medical device
#medtech
 Feedback